Deletion of CDKN2A gene or silencing of its expression by promoter methylation is prevalent in several human cancers, consistent with CDKN2A being a tumour suppressor gene. Furthermore, IRF7 promotes immune surveillance by natural killer and T cells.47 The gene discussed is CDKN2A; the disease is neoplasm.